Skip to Main Content

Author Details

Tony Hunter
Salk Institute for Biological Studies
1968
538
167
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35978494Signatures of increasing environmental stress in bumblebee wings over the past century: Insights from museum specimens.J Anim Ecol2023
35978494Signatures of increasing environmental stress in bumblebee wings over the past century: Insights from museum specimens.J Anim Ecol2023
37745372Inhibiting Stromal Class I HDACs Curbs Pancreatic Cancer Progression.bioRxiv2023
37572655CTLA-4 blockade induces a microglia-Th1 cell partnership that stimulates microglia phagocytosis and anti-tumor function in glioblastoma.Immunity2023
38057326Inhibiting stromal Class I HDACs curbs pancreatic cancer progression.Nat Commun2023
36811280Eddy Fischer-Renaissance scientist and bon viveur.IUBMB Life2023
37221017MAP4K3 inhibits Sirtuin-1 to repress the LKB1-AMPK pathway to promote amino acid-dependent activation of the mTORC1 complex.Life Sci Alliance2023
37745372Inhibiting Stromal Class I HDACs Curbs Pancreatic Cancer Progression.bioRxiv2023
38057326Inhibiting stromal Class I HDACs curbs pancreatic cancer progression.Nat Commun2023
37572655CTLA-4 blockade induces a microglia-Th1 cell partnership that stimulates microglia phagocytosis and anti-tumor function in glioblastoma.Immunity2023
37221017MAP4K3 inhibits Sirtuin-1 to repress the LKB1-AMPK pathway to promote amino acid-dependent activation of the mTORC1 complex.Life Sci Alliance2023
36811280Eddy Fischer-Renaissance scientist and bon viveur.IUBMB Life2023
36277993Eicosanoids in the pancreatic tumor microenvironment - a multicellular, multifaceted progression.Gastro Hep Adv2022
35654043A journey from phosphotyrosine to phosphohistidine and beyond.Mol Cell2022
36277993Eicosanoids in the pancreatic tumor microenvironment - a multicellular, multifaceted progression.Gastro Hep Adv2022
37200937The 'New (Nu)-clear' evidence for the tumor-driving role of PI3K.Acta Mater Med2022
35654043A journey from phosphotyrosine to phosphohistidine and beyond.Mol Cell2022
37200937The 'New (Nu)-clear' evidence for the tumor-driving role of PI3K.Acta Mater Med2022
33388338Quantitative assessment of NFκB transcription factor activity.J Immunol Methods2021
33846527An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy.Commun Biol2021
34087162Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma.Cancer Cell2021
33547238Structural basis for differential recognition of phosphohistidine-containing peptides by 1-pHis and 3-pHis monoclonal antibodies.Proc Natl Acad Sci U S A2021
33495455Emerging functions of branched ubiquitin chains.Cell Discov2021
33397984Spatiotemporal profiling of cytosolic signaling complexes in living cells by selective proximity proteomics.Nat Commun2021
33388338Quantitative assessment of NFκB transcription factor activity.J Immunol Methods2021
34624072The many ways that nature has exploited the unusual structural and chemical properties of phosphohistidine for use in proteins.Biochem J2021
34848876Author Correction: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring.Nature2021
33547238Structural basis for differential recognition of phosphohistidine-containing peptides by 1-pHis and 3-pHis monoclonal antibodies.Proc Natl Acad Sci U S A2021
33846527An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy.Commun Biol2021
33495455Emerging functions of branched ubiquitin chains.Cell Discov2021
34848876Author Correction: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring.Nature2021
34624072The many ways that nature has exploited the unusual structural and chemical properties of phosphohistidine for use in proteins.Biochem J2021
34087162Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma.Cancer Cell2021
33397984Spatiotemporal profiling of cytosolic signaling complexes in living cells by selective proximity proteomics.Nat Commun2021
32116793Tuft Cell Formation Reflects Epithelial Plasticity in Pancreatic Injury: Implications for Modeling Human Pancreatitis.Front Physiol2020
32116793Tuft Cell Formation Reflects Epithelial Plasticity in Pancreatic Injury: Implications for Modeling Human Pancreatitis.Front Physiol2020
32392889The Potential Functional Roles of NME1 Histidine Kinase Activity in Neuroblastoma Pathogenesis.Int J Mol Sci2020
31707661Subcellular Localization of Histidine Phosphorylated Proteins Through Indirect Immunofluorescence.Methods Mol Biol2020
31707659Empirical Evidence of Cellular Histidine Phosphorylation by Immunoblotting Using pHis mAbs.Methods Mol Biol2020
31707660Immunohistochemistry (IHC): Chromogenic Detection of 3-Phosphohistidine Proteins in Formaldehyde-Fixed, Frozen Mouse Liver Tissue Sections.Methods Mol Biol2020
32823988NME/NM23/NDPK and Histidine Phosphorylation.Int J Mol Sci2020
32743569The D614G mutation in the SARS-CoV2 Spike protein increases infectivity in an ACE2 receptor dependent manner.bioRxiv2020
31707661Subcellular Localization of Histidine Phosphorylated Proteins Through Indirect Immunofluorescence.Methods Mol Biol2020
31707659Empirical Evidence of Cellular Histidine Phosphorylation by Immunoblotting Using pHis mAbs.Methods Mol Biol2020
31707660Immunohistochemistry (IHC): Chromogenic Detection of 3-Phosphohistidine Proteins in Formaldehyde-Fixed, Frozen Mouse Liver Tissue Sections.Methods Mol Biol2020
32743569The D614G mutation in the SARS-CoV2 Spike protein increases infectivity in an ACE2 receptor dependent manner.bioRxiv2020
32823988NME/NM23/NDPK and Histidine Phosphorylation.Int J Mol Sci2020
32392889The Potential Functional Roles of NME1 Histidine Kinase Activity in Neuroblastoma Pathogenesis.Int J Mol Sci2020
30583959Repair of protein-linked DNA double strand breaks: Using the adenovirus genome as a model substrate in cell-based assays.DNA Repair (Amst)2019
30593505An internal ribosome entry site in the coding region of tyrosyl-DNA phosphodiesterase 2 drives alternative translation start.J Biol Chem2019
  • 1 - 50 of 1,076

Recommended Authors

Erin D Jeffery
Agenus Inc, American Society for Mass Spectrometry, Hartwick College, Human Proteome Organisation, Large Scale Biology Corp, University of Virginia
Career Start Year 2005
Number of shared co-authors 2
Genevi??ve Lavoie
Institute for Research in Immunology and Cancer (IRIC)
Career Start Year 2004
Number of shared co-authors 1
Rachel Toth
University of Dundee
Career Start Year 1999
Number of shared co-authors 2
Charles James Hastie
University of Dundee
Career Start Year 1998
Number of shared co-authors 2
Karen H Martin
West Virginia University Cancer Institute, West Virginia University
Career Start Year 1993
Number of shared co-authors 0
Manfred Koegl
Boehringer Ingelheim RCV GmbH & Co. KG
Career Start Year 1993
Number of shared co-authors 1
Jiefei Tong
Hospital for Sick Children
Career Start Year 1993
Number of shared co-authors 1
Ailan Guo
College of Animal Medicine, Xinjiang Agricultural University
Career Start Year 1992
Number of shared co-authors 1
Christoph Reinhard
Lilly Research Laboratories
Career Start Year 1992
Number of shared co-authors 1
Alex Vassilev
National Institute of Child Health & Human Development, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Stephan M Feller
Institute of Molecular Medicine, Martin-Luther-University of Halle-Wittenberg
Career Start Year 1989
Number of shared co-authors 0
Kun-Liang Guan
University of California San Diego
Career Start Year 1988
Number of shared co-authors 11
Nic Jones
Cancer Research United Kingdom Manchester Institute, University of Manchester
Career Start Year 1988
Number of shared co-authors 0
John Rush
Cell Signaling Technology Inc.
Career Start Year 1987
Number of shared co-authors 0
Claudio Schneider
Laboratorio Nazionale-Consorzio Interuniversitario per le Biotecnologie
Career Start Year 1987
Number of shared co-authors 4
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 7
Michael F Moran
Hospital for Sick Children, University of Toronto
Career Start Year 1985
Number of shared co-authors 2
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Career Start Year 1984
Number of shared co-authors 9
Hediye Erdjument-Bromage
Neuroscience Institute, NYU Grossman School of Medicine
Career Start Year 1984
Number of shared co-authors 3
Sylvain Meloche
Institute for Research in Immunology and Cancer
Career Start Year 1982
Number of shared co-authors 1
Siu-Pok Yee
University of Connecticut Health Center
Career Start Year 1981
Number of shared co-authors 1
J. Wade Harper
Harvard Medical School
Career Start Year 1981
Number of shared co-authors 9
Ze'ev Ronai
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1981
Number of shared co-authors 10
Sara A Courtneidge
Oregon Health & Science University
Career Start Year 1977
Number of shared co-authors 0
Joseph B Bolen
University of California San Francisco
Career Start Year 1977
Number of shared co-authors 3
Frank McCormick
Frederick National Laboratory for Cancer Research
Career Start Year 1975
Number of shared co-authors 6
Hartmut Land
University of Rochester Medical Center, Wilmot Cancer Institute
Career Start Year 1974
Number of shared co-authors 0
Jonathan M Backer
Albert Einstein College of Medicine
Career Start Year 1970
Number of shared co-authors 4
Charles J Sherr
St. Jude Children's Research Hospital
Career Start Year 1968
Number of shared co-authors 2
John T Parsons
The School of Medicine, University of Virginia
Career Start Year 1966
Number of shared co-authors 2

Collaborators

Jill Meisenhelder
Salk Institute
Co-authored papers 31
Inder M Verma
Co-authored papers 16
Aaron Aslanian
Salk Institute for Biological Studies
Co-authored papers 15
John R Yates
TheScripps Research Institute
Co-authored papers 13
Michael Karin
Co-authored papers 10
Tony Pawson
Co-authored papers 9
James R Woodgett
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 8
Ronald M Evans
Co-authored papers 8
Gerald M Pao
Co-authored papers 7
Clare M Isacke
Co-authored papers 6
Gerard Manning
Genentech Inc.
Co-authored papers 6
Andrew Dillin
Howard Hughes Medical Institute, The University of California berkeley
Co-authored papers 5
Michael Downes
Howard Hughes Medical Institute, Salk Institute for Biological Studies
Co-authored papers 5
Erich A Nigg
University of Basel
Co-authored papers 4
Daniel D Von Hoff
Co-authored papers 4
Wei Yang
Co-authored papers 3
Eric A Collisson
University of California san francisco
Co-authored papers 3
Caroline Grabbe
Umea University
Co-authored papers 3
Timothy T Harkins
NVIDIA Corporation
Co-authored papers 3
Christopher Benner
Michigan State University College of Human Medicine
Co-authored papers 3
Lewis C Cantley
Co-authored papers 3
Kenneth Aldape
National Cancer Institute
Co-authored papers 3
Arthur Weiss
University of California san francisco
Co-authored papers 3
Gerry Weinmaster
David Geffen School of Medicine, University of California-Los Angeles
Co-authored papers 2
Rama Ranganathan
Co-authored papers 2
Anne-Claude Gingras
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 2
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Co-authored papers 2
Anthony Bretscher
Weill Institute for Cell and Molecular Biology, Cornell University
Co-authored papers 2
Matthew D Weitzman
The Children's Hospital of Philadelphia
Co-authored papers 2
Susan S Taylor
University of California
Co-authored papers 2
Release 1.2